Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Divi's Laboratories Limited

Market Cap 1,754B 18.53B 15.98B 14.71B 13.82B 25.92B 26.2B 174B 67.88B 857B 69.51B 68.04B 2,971B P/E Ratio 2026
61.5x
P/E Ratio 2027 * 58.9x
Enterprise Value 1,721B 18.17B 15.67B 14.43B 13.55B 25.42B 25.7B 170B 66.58B 841B 68.17B 66.73B 2,914B EV / Sales 2026
14.6x
EV / Sales 2027 * 14x
Free-Float
47.98%
Yield 2026
0.5%
Yield 2027 * 0.54%
1 day-0.44%
1 week-0.22%
Current month-0.88%
1 month-4.52%
3 months+8.85%
6 months+2.83%
Current year+3.38%
1 week 6,535
Extreme 6535
6,815
1 month 6,450.5
Extreme 6450.5
6,960.5
Current year 5,647.5
Extreme 5647.5
6,968
1 year 5,636.5
Extreme 5636.5
7,071.5
3 years 3,295.3
Extreme 3295.3
7,071.5
5 years 2,730
Extreme 2730
7,071.5
10 years 532.65
Extreme 532.65
7,071.5
Manager TitleAgeSince
Chief Executive Officer 75 2009-11-25
Chief Executive Officer 48 2020-01-03
Director of Finance/CFO 65 2025-07-31
Director TitleAgeSince
Director/Board Member 48 2009-11-25
Chairman 75 2009-11-25
Director/Board Member 68 1994-09-30
Date Insider Type Main position Quantity % Market Cap.
25-03-25Sell

Executive/Senior Manager

25,000 0.0094%
25-03-14Sell 300 0.0001%
25-02-16Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%-0.22%-0.88%+89.58% 18.54B
-0.32%-0.18%+37.83%+152.24% 1,010B
-2.16%+1.24%+50.01%+45.87% 580B
-2.70%-2.48%+15.97%+62.66% 402B
+0.77%0.00%+21.28%+19.14% 330B
-1.52%+1.90%+23.73%+34.08% 281B
-1.95%-4.75%+20.15%+14.68% 280B
-0.57%+0.62%-44.67%-47.65% 197B
-1.31%+0.27%+18.74%+57.70% 192B
-0.38%-3.76%+13.02%+59.46% 156B
Average -0.49%+0.78%+15.52%+48.78% 344.73B
Weighted average by Cap. -0.23%+1.03%+26.05%+69.11%

Financials

2026 2027 *
Net sales 106B 1.12B 970M 893M 838M 1.57B 1.59B 10.55B 4.12B 52.02B 4.22B 4.13B 180B 123B 1.3B 1.12B 1.03B 967M 1.81B 1.83B 12.16B 4.75B 59.98B 4.86B 4.76B 208B
Net income 25.58B 270M 233M 215M 201M 378M 382M 2.53B 990M 12.5B 1.01B 992M 43.32B 30.29B 320M 276M 254M 239M 447M 452M 3B 1.17B 14.8B 1.2B 1.17B 51.3B
Net Debt -33.83B -357M -308M -284M -266M -500M -505M -3.35B -1.31B -16.53B -1.34B -1.31B -57.29B -33.41B -353M -304M -280M -263M -494M -499M -3.31B -1.29B -16.33B -1.32B -1.3B -56.58B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
10,542
Date Price Change Volume
26-06-15 6,608.50 -0.44% 196,206
26-06-12 6,638.00 -0.26% 162,810
26-06-11 6,655.50 +0.26% 228,572
26-06-10 6,638.50 -1.70% 405,743
26-06-09 6,753.00 +3.56% 912,179
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
6,608.50INR
Average target price
7,065.83INR
Spread / Average Target
+6.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!